Prospective assessment of autism traits in children exposed to antiepileptic drugs during pregnancy

Epilepsia

Volumn 56, Issue 7, 2015, Pages 1047-1055

  Wood, Amanda G ^a,b,c   Nadebaum, Caroline ^a,b   Anderson, Vicki ^a,d   Reutens, David ^e   Barton, Sarah ^a,b   O'Brien, Terence J ^d   Vajda, Frank ^d,f  

^a MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e UNIVERSITY OF QUEENSLAND   (Australia)

^f Australian Pregnancy Register for Women on Antiepileptic Medication   (Australia)

Author keywords

Anticonvulsant; Autism spectrum; Neurodevelopment; Prenatal; Valproate

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLONAZEPAM; ETHOSUXIMIDE; ETIRACETAM; FOLIC ACID; GABAPENTIN; LAMOTRIGINE; PHENYTOIN; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

ADOLESCENT; ARTICLE; AUSTRALIAN; AUTISM; CANNABIS USE; CHILD; CHILDHOOD AUTISM RATING SCALE; COHORT ANALYSIS; DRUG EXPOSURE; EPILEPSY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; INTELLIGENCE QUOTIENT; MAJOR CLINICAL STUDY; MALE; MATERNAL EPILEPSY; MATERNAL INTELLIGENCE QUOTIENT; MONOTHERAPY; PREDICTOR VARIABLE; PREGNANCY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RATING SCALE; REGISTER; SCORING SYSTEM; SOCIAL STATUS; SUPPLEMENTATION; TOBACCO; AUSTRALIA; AUTISTIC DISORDER; CHEMICALLY INDUCED; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE;

ANTICONVULSANTS; AUSTRALIA; AUTISTIC DISORDER; CHILD; COHORT STUDIES; EPILEPSY; FEMALE; HUMANS; MALE; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; PROSPECTIVE STUDIES;

EID: 84936746872     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/epi.13007     Document Type: Article

References (39)

1. Tomson T, Battino D, Bonizzoni E, et al., Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol 2011; 10: 609-617.
2. Holmes LB, Mittendorf R, Shen A, et al., Fetal effects of anticonvulsant polytherapies: different risks from different drug combinations. Arch Neurol 2011; 68: 1275-1281.
3. Bromley R, Weston J, Adab N, et al., Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child (Review). Cochrane Database Syst Rev 2014; 10: CD010236.
4. Vajda FJ, Hitchcock A, Graham J, et al., The Australian Register of antiepileptic drugs in pregnancy: the first 1002 pregnancies. Aust N Z J Obstet Gynaecol 2007; 47: 468-474.
5. Meador KJ, Baker GA, Browning N, et al., Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med 2009; 360: 1597-1605.
6. Williams G, King J, Cunningham M, et al., Fetal valproate syndrome and autism: additional evidence of an association. Dev Med Child Neurol 2001; 43: 202-206.
7. Moore SJ, Turnpenny P, Quinn A, et al., A clinical study of 57 children with fetal anticonvulsant syndromes. J Med Genet 2000; 37: 489-497.
8. Rasalam AD, Hailey H, Williams JHG, et al., Characteristics of fetal anticonvulsant syndrome associated autistic disorder. Dev Med Child Neurol 2005; 47: 551-555.
9. Dean JCS, Hailey H, Moore SJ, et al., Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth. J Med Genet 2002; 39: 251-259.
10. Schneider T, Przewlocki R,. Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism. Neuropsychopharmacology 2005; 30: 80-89.
11. Bromley RL, Mawer G, Clayton-Smith J, et al., Autism spectrum disorders following in utero exposure to antiepileptic drugs. Neurology 2008; 71: 1923-1924.
12. Christensen J, Grønborg TK, Sørensen MJ, et al., Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA 2013; 309: 1696-1703.
13. Veiby G, Daltveit AK, Schjølberg S, et al., Exposure to antiepileptic drugs in utero and child development: a prospective population-based study. Epilepsia 2013; 54: 1462-1472.
14. Williams K, MacDermott S, Ridley G, et al., The prevalence of autism in Australia. Can it be established from existing data? J Paediatr Child Health 2008; 44: 504-510.
15. Elsabbagh M, Divan G, Koh YJ, et al., Global prevalence of autism and other pervasive developmental disorders. Autism Res 2012; 5: 160-179.
16. Riley M, Haliday J,. Birth defects in Victoria 1983-1988. Perinatal Data Collection Unit, Melbourne Public Health Division, Department of Human Services. Australia; 1988.
17. Schendel DE, Autry A, Wines R, et al., The co-occurrence of autism and birth defects: prevalence and risk in a population-based cohort. Dev Med Child Neurol 2009; 51: 779-786.
18. Clarke DF, Roberts W, Daraksan M, et al., The prevalence of autistic spectrum disorder in children surveyed in a tertiary care epilepsy clinic. Epilepsia 2005; 46: 1970-1977.
19. Wechsler D,. Wechsler abbreviated scale of intelligence. The Psychological Corporation, San Antonio, TX; 1999.
20. Jones FL, McMillan J,. Scoring occupational categories for social research: a review of current practice, with Australian examples. Work Employ Soc 2001; 15: 539-563.
21. Schopler E, Reichler R, Renner B,. The Childhood Autism Rating Scale (CARS). Los Angeles, CA: Western Psychological Services; 1988.
22. Perry A, Condillac R, Freeman N, et al., Multi-site study of the Childhood Autism Rating Scale (CARS) in five clinical groups of young children. J Autism Dev Disord 2005; 35: 625-635.
23. Magyar CI, Pandolfi V,. Factor structure evaluation of the childhood autism rating scale. J Autism Dev Disord 2007; 37: 1787-1794.
24. Ventola PE, Kleinman J, Pandey J, et al., Agreement among four diagnostic instruments for autism spectrum disorders in toddlers. J Autism Dev Disord 2006; 36: 839-847.
25. Pilowsky T, Yirmiya N, Shulman C, et al., The Autism Diagnostic Interview-Revised and the Childhood Autism Rating Scale: differences between diagnostic systems and comparison between genders. J Autism Dev Disord 1998; 28: 143-151.
26. Turkheimer E, Haley A, Waldron M, et al., Socioeconomic status modifies heritability of IQ in young children. Psychol Sci 2003; 14: 623-628.
27. Whitley E, Gale CR, Deary IJ, et al., Association of maternal and paternal IQ with offspring conduct, emotional and attention problem scores: trans-generational evidence from the 1958 British birth cohort study. Arch Gen Psychiatry 2011; 68: 1032-1038.
28. Nadebaum C, Anderson V, Vajda F, et al., The Australian brain and cognition and antiepileptic drugs study: IQ in school-aged children exposed to sodium valproate and polytherapy. J Int Neuropsychol Soc 2011; 17: 133-142.
29. Nadebaum C, Anderson VA, Vajda F, et al., Language skills of school-aged children prenatally exposed to antiepileptic drugs. Neurology 2011; 76: 719-726.
30. Vajda FJ, Eadie MJ,. Maternal valproate dosage and foetal malformations. Acta Neurol Scand 2005; 112: 137-143.
31. Vajda FJ, Hitchcock AA, Graham J, et al., The teratogenic risk of antiepileptic drug polytherapy. Epilepsia 2010; 51: 805-810.
32. Vajda FJ, O'Brien TJ, Hitchcock A, et al., Critical relationship between sodium valproate dose and human teratogenicity: results of the Australian register of anti-epileptic drugs in pregnancy. J Clin Neurosci 2004; 11: 854-858.
33. Baker GA, Bromley RL, Briggs M, et al., IQ at 6 years after in utero exposure to antiepileptic drugs: a controlled cohort study. Neurology 2015; 84: 382-390.
34. Cohen MJ, Meador KJ, Browning N, et al., Fetal antiepileptic drug exposure: motor, adaptive, and emotional/behavioral functioning at age 3 years. Epilepsy Behav 2011; 22: 240-246.
35. Rogers S, Vismara L,. Evidence-based comprehensive treatments for early autism. J Clin Child Adolesc Psychol 2008; 37: 8-38.
36. Falkmer T, Anderson K, Fau-Falkmer M, et al., Diagnostic procedures in autism spectrum disorders: a systematic literature review. Eur Child Adolesc Psychiatry 2013; 22: 329-340.
37. Tomson T, Battino D, French J, et al., Antiepileptic drug exposure and major congenital malformations: the role of pregnancy registries. Epilepsy Behav 2007; 11: 277-282.
38. Mayes SD, Calhoun SL, Murray MJ, et al., Use of the Childhood Autism Rating Scale (CARS) for children with high functioning autism or asperger syndrome. Focus Autism Other Dev Disabl 2012; 27: 31-38.
39. Dawson G,. Early behavioral intervention, brain plasticity, and the prevention of autism spectrum disorder. Dev Psychopathol 2008; 20: 775-803.